A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer Academic Article uri icon

Overview

MeSH Major

  • Contraceptive Agents, Male
  • Drug Resistance, Neoplasm
  • Gossypol
  • Lung Neoplasms
  • Neoplasm Recurrence, Local
  • Small Cell Lung Carcinoma

abstract

  • AT-101 is not active in patients with recurrent chemosensitive SCLC.

publication date

  • October 2011

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3180914

Digital Object Identifier (DOI)

  • 10.1097/JTO.0b013e31822e2941

PubMed ID

  • 21918390

Additional Document Info

start page

  • 1757

end page

  • 60

volume

  • 6

number

  • 10